Expected earnings - Chemomab Therapeutics Ltd.
Source: US Earnings Reports
Chemomab Therapeutics Ltd. (CMMB) is expected to report $-0.2 for Q2 2025
Chemomab Therapeutics Ltd.
NASDAQ: CMMB
CMMB Trading
5.06% G/L:
$1.87 Last:
15,508 Volume:
$1.81 Open:
CMMB Latest News
February 17, 2026 08:00:00 am
Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
CMMB Stock Data
$8,046,168
4,832,891
1.89%
6
N/A
Biotechnology & Life Sciences
Healthcare
IL
Tel Aviv
